Kuzmin D V, Emelianova A A, Kalashnikova M B, Panteleev P V, Ovchinnikova T V
M. M. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Bull Exp Biol Med. 2017 Apr;162(6):754-757. doi: 10.1007/s10517-017-3705-2. Epub 2017 Apr 20.
We analyze the effects of N-terminal acetylation and C-terminal amidation on the cytotoxic properties of β-hairpin antimicrobial peptide tachyplesin I. MTT-assay showed that modified tachyplesin I exhibited increased cytotoxicity toward both tumor and normal human cells. Hemolytic activity of modified tachyplesin I was also higher than that of the initial molecule. In contrast to non-modified tachyplesin I, the peptide with C- and N-terminal modifications is resistant to proteolytic degradation in fresh human serum. C- and N-terminal modifications make tachyplesin I more attractive prototype of anticancer drug due to its more potent cytotoxic effect and better pharmacokinetic properties.
我们分析了N端乙酰化和C端酰胺化对β-发夹抗菌肽鲎素I细胞毒性特性的影响。MTT检测表明,修饰后的鲎素I对肿瘤细胞和正常人细胞均表现出增强的细胞毒性。修饰后的鲎素I的溶血活性也高于初始分子。与未修饰的鲎素I不同,具有C端和N端修饰的肽在新鲜人血清中对蛋白水解降解具有抗性。由于其更强的细胞毒性作用和更好的药代动力学特性,C端和N端修饰使鲎素I成为更具吸引力的抗癌药物原型。